Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis

Journal of Neurology

Volumn 245, Issue 3, 1998, Pages 149-152

  Weih, M ^a   Vetter, B ^a   Ziemer, S ^a   Mehraein, S ^a   Valdueza, J M ^a   Koscielny, J ^a   Kulozik, A E ^a   Einhaupl K M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Activated protein C resistance; Coagulation system; Stroke; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GERMANY; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTITHROMBIN III; FACTOR V; FEMALE; GERMANY; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; MUTATION; PROTEIN C; PROTEIN S; RETROSPECTIVE STUDIES;

EID: 0031891060     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050195     Document Type: Article

References (24)

1. Ameri A, Bousser MG (1992) Cerebral venous thrombosis. Neurol Clin 10:87-111
2. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, Ronde H de, Velden PA van der, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
3. Bousser MG, Gujon C, Ribeiro V, Chiras J (1990) Diagnostic strategies in cerebral sinus vein thrombosis. In: Einhäupl KM, Kempski O, Baethmann A (eds) Cerebral sinus thrombosis. Plenum Press, New York, pp 187-200
4. Briet E, Broekmans AW, Engesser L (1988) Hereditary protein S deficiency. In: Bertina RM (ed) Protein C and related proteins. Churchill Livingstone, Edinburgh, pp 203-210
5. Dahlback B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008
6. De Stefano V, Finazzi G, Mannucci PM (1996) Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 87:3531-3544
7. Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG (1996) Coagulation studies, factor V Leiden, and anti-cardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27:1724-1730
8. Einhäupl KM, Masuhr F (1994) Cerebral venous and sinus thrombosis - an update. Eur J Neurol 1:109-126
9. Emmerich J, Poirier O, Evans A, Marques Vidal P, Arveiler D, Luc G, Aiach M, Cambien F (1995) Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet 345:321
10. Frezzato M, Tosetto A, Rodeghiero F (1996) Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 143:1257-1265
11. Gram J, Jespersen J (1985) Improved assay of antithrombin-III. Effects of certain additives on thrombin and on chromogenic peptide substrates. Clin Chem 31:1683-1688
12. Heijer M den, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759-762
13. Koster T, Rosendaal FR, Ronde H de, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506
14. Martinelli I, Landi G, Maerati G, Cella R, Tosetto A, Mannuci PM (1996) Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 75:393-394
15. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703
16. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346:1133-1134
17. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912-917
18. Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277:1305-1307
19. Schroder W, Koessling M, Wulff K, Wehnert M, Herrmann FH (1996) World distribution of factor V Leiden mutation. Lancet 347:58-59
20. Svensson PJ, Dahlback B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522
21. Triplett DA, Brandt J (1989) Laboratory identification of the lupus anticoagulant. Br J Haematol 73:139-142
22. Uttenreuther-Fischer MM, Vetter B, Hellmann C, Otting U, Ziemer S, Hausdorf G, Gaedicke G, Kulozik AE (1997) Paediatric thromboembolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 156:277-281
23. Wolf M, Boyer Neumann C, Martinoli JL, Leroy Matheron C, Amiral J, Meyer D. Larrieu MJ (1989) A new functional assay for human protein S activity using activated factor V as substrate. Thromb Haemost 62:1144-1145
24. Zuber M, Toulon P, Marnet L, Mas JL (1996) Factor V Leiden mutation in cerebral venous thrombosis. Stroke 27:1721-1723